Mar 11, 2025 4:30pm EDT Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum
Mar 06, 2025 6:31am EST Stevanato Group Reports Record Revenue of €1,104 Million for Fiscal Year 2024
Feb 24, 2025 4:02pm EST Stevanato Group to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 6, 2025
Oct 22, 2024 4:30pm EDT Stevanato Group to Report Third Quarter 2024 Financial Results on November 5, 2024
Oct 01, 2024 6:30am EDT Stevanato Group Will Introduce Its Large-Volume Vertiva® 10mL On-Body Delivery System Platform for Injectable Therapies at CPHI Milan
Sep 26, 2024 7:04am EDT Stevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry “Alliance for RTU”